Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol vs propofol sedation for gastroenteroscopy in overweight or obese adults
ChiCTR2200062970Phase 4Recruiting
- Sponsor
- Renji Hospital
- Start
- Aug 2022
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Overweight and obesity comparing Ciprofol injection with Propofol injection (2 arms). Primary endpoints: Body mass index (BMI) and Peripheral capillary oxygen saturation (SpO2). Started Aug 2022; status: recruiting.
02
Drugs
ciprofolpropofol
03
Conditions
Overweightobesity
Beyond the preview
Go deeper on ChiCTR2200062970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062970.